EUVIMEDEUVIMED entdecken
Crossref

Clinical biomarker–based biological ageing and the risk of adverse outcomes in patients with chronic kidney disease

Hao Xiang, Yu Huang, Yuanyuan Zhang, Panpan He, Ziliang Ye, Sisi Yang, Yanjun Zhang, Xiaoqin Gan, Fan Fan Hou, Xianhui Qin iD

Age and Ageing · 01.11.2024 · 53 (11)

DOI: 10.1093/ageing/afae245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 14.11.2024. Verfasst von Hao Xiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Nanfang Hospital, Southern Medical University; National Clinical Research Center for Kidney Disease; State Key Laboratory of …. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Kidney Failure, Chronic, Cardiovascular Diseases, Biomarkers. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Patients with chronic kidney disease (CKD) show features of premature ageing. We aimed to evaluate the association between biological ageing and adverse outcomes, including end-stage kidney disease (ESKD), cardiovascular diseases (CVD) and all-cause mortality, in patients with CKD.

Methods

23 435 participants with CKD and free of related adverse outcomes at baseline from the UK Biobank were included. Leukocyte telomere length (LTL) was measured by quantitative polymerase chain reaction assay. Clinical biomarker–based biological ages were quantified using Klemera–Doubal method biological age (KDM-BA) and PhenoAge algorithms.

Results

During a median follow-up of 12 years, 3417 incident CVD, 383 incident ESKD and 3195 all-cause mortality were recorded. Per SD increment of KDM-BA acceleration was associated with a 56% [95% confidence interval (CI): 41%–73%], 26% (95% CI: 21%–31%) and 39% (95% CI: 34%–44%) increase in the risk of incident ESKD, incident CVD and all-cause mortality, respectively. Similar results were found for PhenoAge acceleration. LTL (per SD increment) was inversely associated with the risk of incident CVD [hazard ratio (HR): 0.96, 95% CI: 0.92–0.99] and all-cause mortality (HR: 0.94, 95% CI: 0.91–0.98) and was not significantly associated with the risk of incident ESKD (HR: 0.96, 95% CI: 0.86–1.06). Adding KDM-BA acceleration or PhenoAge acceleration, but not LTL, to the traditional validated clinical prediction models significantly improved the predictive performance for incident ESKD, all-cause mortality and CVD.

Conclusion

In patients with CKD, both KDM-BA acceleration and PhenoAge acceleration were associated with an increased risk of ESKD, CVD and all-cause mortality, and KDM-BA or PhenoAge may be a better predictor on adverse outcomes than LTL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicKidney Failure, ChronicCardiovascular DiseasesBiomarkersHumansMaleFemaleMiddle AgedAgedRisk FactorsAgingRisk AssessmentUnited KingdomAge FactorsTelomereCause of DeathAdultIncidenceLeukocytesPrognosis

Stichwörter der Autor:innen

biological ageingcardiovascular diseasechronic kidney diseaseend-stage kidney diseasemortalityolder people

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Division of Nephrology, Nanfang Hospital, Southern Medical University; National Clinical Research Center for Kidney Disease; State Key Laboratory of Organ Failure Research; Guangdong Provincial Institute of Nephrology;…

ORCID-Profile: Xianhui Qin

Zitieren

APA

Xiang, H., Huang, Y., Zhang, Y., He, P., Ye, Z., Yang, S., Zhang, Y., Gan, X., Hou, F. F., & Qin, X. (2024). Clinical biomarker–based biological ageing and the risk of adverse outcomes in patients with chronic kidney disease. Age and Ageing, 53(11). https://doi.org/10.1093/ageing/afae245

Vancouver

Xiang H, Huang Y, Zhang Y, He P, Ye Z, Yang S, et al. Clinical biomarker–based biological ageing and the risk of adverse outcomes in patients with chronic kidney disease. Age and Ageing. 2024;53(11). doi:10.1093/ageing/afae245

BibTeX
@article{Xiang2024,
  author = {Xiang, Hao and Huang, Yu and Zhang, Yuanyuan and He, Panpan and Ye, Ziliang and Yang, Sisi and Zhang, Yanjun and Gan, Xiaoqin and Hou, Fan Fan and Qin, Xianhui},
  title = {Clinical biomarker–based biological ageing and the risk of adverse outcomes in patients with chronic kidney disease},
  journal = {Age and Ageing},
  year = {2024},
  volume = {53},
  number = {11},
  doi = {10.1093/ageing/afae245}
}
Kostenlos starten →